Market Intelligence chevron_right Medical Devices & Consumables chevron_right Pulmonary Administration
Global Report 2024

Global Pulmonary Administration Market Growth 2024-2030

calendar_todayPublished: Jun 2024 descriptionPages: 165 categoryCategory: Medical Devices & Consumables
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD, and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.

The global Pulmonary Administration market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Pulmonary Administration Industry Forecast” looks at past sales and reviews total world Pulmonary Administration sales in 2023, providing a comprehensive analysis by region and market sector of projected Pulmonary Administration sales for 2024 through 2030.

Segmentation by Type:

  • Pressurized Metered Dose Inhalation System
  • Dry Powder Inhalation System
  • Soft Mist Inhalation System
  • Others

Segmentation by Application:

  • Bronchial Asthma
  • Chronic Obstructive Pulmonary Disease
  • Others

Market by Region:

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Companies Coverage:

  • Aptar Pharma
  • Nemera
  • Porex
  • Chiesi Farmaceutici
  • AstraZeneca
  • H&T Presspart
  • Gerresheimer
  • Merxin Ltd
  • 3M
  • Aerogen Pharma
  • MedPharm
  • Kindeva Drug Delivery
  • Boehringer Ingelheim
  • Chiesi Farmaceutici SpA
  • Merck & Co, Inc
  • Novartis AG
  • PARI international
  • Vectura Group Plc
  • GlaxoSmithKline
  • Koninklijke Philips NV
  • OMRON Corporation
  • Sunovion Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd
  • Yisuo Intelligent

Key Questions Addressed in this Report:

  • What is the 10-year outlook for the global Pulmonary Administration market?
  • What factors are driving Pulmonary Administration market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Pulmonary Administration market opportunities vary by end market size?
  • How does Pulmonary Administration break out by Type, by Application?

Frequently Asked Questions

What is the USP of the report? expand_more
Pulmonary Administration report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Pulmonary Administration report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Pulmonary Administration report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.